期刊文献+

结缔组织生长因子基因RNA干扰复制缺陷型腺病毒载体的构建及鉴定 被引量:1

Construction and Identification of Replication-Deficient Adenovirus Vector for RNA Interference with CTGF Gene
下载PDF
导出
摘要 目的:构建能介导结缔组织生长因子(CTGF)基因RNA干扰的复制缺陷型腺病毒表达载体。方法:以大鼠CTGF基因为靶序列,设计并合成含编码短发夹RNA序列的寡核苷酸,构建腺病毒穿梭质粒p-shuttle-CTGF,酶切及测序分析正确后,与腺病毒骨架质粒pAdEasy-1共转染AD-293细胞,进行病毒包装,得到腺病毒载体Ad.H1-CTGF,用该载体感染HSC-T6细胞,观察其对CTGF基因表达抑制的效果。结果:构建的腺病毒穿梭质粒p-shuttle-CTGF经酶切、测序分析证实正确;包装的病毒载体滴度为4×1010PFU/mL,感染HSC-T6细胞后,Western印迹证实CTGF表达显著减少。结论:构建的腺病毒载体Ad.H1-CTGF可有效抑制HSC-T6中CTGF的表达,为抗纤维化研究提供了有力的工具。 Objective: To construct a replication-deficient recombinant adenovirus vector expressing small interfer- ence RNA(siRNA) against the connective tissue growth factor(CTGF) gene. Methods: The siRNA sequence target- ing CTGF mRNA was synthesized and shuttle plasmid p-shuttle-CTGF was constructed, which was co-transfected into AD-293 cells with the bone plasmid pAdEasy-1 to obtain the homologous recombination adenovirus vector Ad.H1-CTGF. The concentration of CTGF protein in HSC-T6 cells infected with adenovirus vector Ad.H1-CTGF was determined by Wetsern blot. Results: The p-shuttle-CTGF was identified by endonuclease and sequencing. The adenovirus vector Ad.H1-CTGF was successfully constructed with the titre of 4×1010 PFU/mL by purification. The concentration of CTGF protein in HSC-T6 ceils was decreased observably after Ad.H1-CTGF infected by Western blot. Conclusion: The constructed Ad.H1-CTGF can effectively inhit the expression of CTGF in HSC-T6 ceils, which provided a powerful tool for anti-fibrosis study.
出处 《生物技术通讯》 CAS 2013年第1期57-60,共4页 Letters in Biotechnology
基金 国家自然科学基金(30571658)
关键词 结缔组织生长因子 RNA干扰 腺病毒载体 connective tissue growth factor RNA interference adenovirus vector
  • 相关文献

参考文献13

  • 1Caruso M,Khiem P N,Kwong Y L. Adenovirus-mediat-ed interleukin-12 gene therapy for metastatic colon carcinoma[J].{H}Proceedings of the National Academy of Sciences(USA),1996.11302-11306.
  • 2Ito Y,Goldschmeding R,Bende R. Kinetics of connec-tive tissue growth factor expression during experimental prolif-erative glomerulonephritis[J].{H}Journal of the American Society of Nephrology,2002.472-484.
  • 3Hannon G L. RNA inteference[J].{H}NATURE,2002.244-251.
  • 4Tuschl T. Expanding small RNA interference[J].Nat Biotech-nol,2002,(05):446-448.
  • 5Reynolds A,Leake D,Boese Q. Rathonal siRNA de-sign for RNA interference[J].{H}Nature Biotechnology,2004,(03):326-330.
  • 6Bedosa P,Paradis V. Approaches foe treatment of liver fibro-sis in chronic hepatitis C[J].Lin Liver Dis,2003.195-210.
  • 7Paradis V,Dargere D,Bonvoust F. Effect and regula-tion of connective tissue growth factor on hepatic stellate cells[J].{H}Laboratory Investigation,2002.767-774.
  • 8Elbashir S M,Lendeckel W,Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].{H}NATURE,2001.428-429.
  • 9Sumimoto H,Yamagata S,Shimizu A. Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference[J].{H}Gene Therapy,2005.95-100.
  • 10Xia H,Mao Q,Paulson H L. siRNA-mediated gene si-lencing in vitro and in vivo[J].{H}Nature Biotechnology,2002.1006-1010.

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部